Dwight Moxie

Insider Reports History

Entity
Individual
Location
7555 Gateway Boulevard, Newark, California
Signature
/s/ Dwight Moxie
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dwight Moxie:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. CLO & GC Performance Stock Units 135K $1.01M $7.47 Jan 31, 2024 Direct
Revance Therapeutics, Inc. CLO & GC Common Stock 138K $695K $5.04 Mar 18, 2024 Direct

Insider Reports Filed by Dwight Moxie

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVNC Revance Therapeutics, Inc. Mar 15, 2024 2 -$58.3K 4 Mar 19, 2024 CLO & GC
RVNC Revance Therapeutics, Inc. Feb 29, 2024 1 $0 4 Mar 4, 2024 CLO & GC
RVNC Revance Therapeutics, Inc. Jan 31, 2024 2 $0 4 Feb 2, 2024 SVP, GC & Secretary
RVNC Revance Therapeutics, Inc. Sep 5, 2023 2 -$613K 4 Sep 7, 2023 SVP, GC & Secretary
RVNC Revance Therapeutics, Inc. Aug 11, 2023 2 -$181K 4 Aug 15, 2023 SVP, GC & Secretary
RVNC Revance Therapeutics, Inc. Mar 15, 2023 1 -$225K 4 Mar 17, 2023 SVP, GC & Secretary
RVNC Revance Therapeutics, Inc. Jan 31, 2023 1 $0 4 Feb 2, 2023 SVP, GC & Secretary
RVNC Revance Therapeutics, Inc. Sep 22, 2022 2 -$584K 4 Mar 9, 2023 SVP, GC & Secretary
RVNC Revance Therapeutics, Inc. Sep 14, 2022 1 -$298K 4 Sep 16, 2022 SVP, GC & Secretary
RVNC Revance Therapeutics, Inc. Mar 15, 2022 2 -$80.7K 4 Mar 17, 2022 SVP, GC & Secretary
RVNC Revance Therapeutics, Inc. Feb 2, 2022 2 -$739K 4 May 16, 2023 SVP, GC & Secretary
RVNC Revance Therapeutics, Inc. Feb 2, 2022 1 $0 4 Feb 4, 2022 SVP, GC & Secretary
RVNC Revance Therapeutics, Inc. Sep 27, 2021 1 -$50.3K 4 Sep 28, 2021 SVP, GC & Secretary